{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:22:08Z","timestamp":1787829728574,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>The co-occurrence of adult-onset immunodeficiency syndrome mediated by anti-interferon-\u03b3 autoantibodies (AIGA-AOID), disseminated non-tuberculous mycobacterial (NTM) infection, and Sweet syndrome is a recognized but underreported triad, particularly in East Asian populations. Detailed case reports emphasizing diagnostic approach and integrated management remain valuable for improving clinical recognition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 70-year-old Asian female presented with a 1-year history of a progressive neck mass, a 6-month history of recurrent fever, and a painful cutaneous eruption on the face, trunk, and limbs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Evaluations revealed disseminated\n                      <jats:italic toggle=\"yes\">Mycobacterium massiliense<\/jats:italic>\n                      infection involving lymph nodes, lung, and skin. Skin biopsy was consistent with Sweet syndrome. High-titer anti-interferon-\u03b3 autoantibodies (1:2500) were detected, confirming AIGA-AOID in the absence of HIV or other immunosuppression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Combined therapy was initiated: rituximab (two weekly doses) with corticosteroids, and a 12-month oral antimycobacterial regimen (clarithromycin, moxifloxacin, linezolid).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient showed marked clinical improvement within 2 weeks, with resolution of fever and skin healing. Follow-up imaging at 3 months demonstrated significant regression of lymphadenopathy and lung consolidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Sweet syndrome can be a presenting sign of disseminated NTM disease. In immunocompetent-appearing adults, especially in endemic regions, this should prompt investigation for AIGA-mediated immunodeficiency. Early diagnosis and combined immunomodulatory-antimicrobial therapy are crucial for successful outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049079","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:05:00Z","timestamp":1780074300000},"page":"e49079","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anti-interferon-\u03b3 autoantibody-mediated immunodeficiency with disseminated Mycobacterium massiliense and secondary Sweet syndrome: A case report"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4449-7496","authenticated-orcid":false,"given":"Jiajia","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The People\u2019s Hospital of Rongchang District, ChongQing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chongqing General Hospital, ChongQing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, The People\u2019s Hospital of Rongchang District, ChongQing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The People\u2019s Hospital of Rongchang District, ChongQing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0606-4573","authenticated-orcid":false,"given":"Jiguang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The People\u2019s Hospital of Rongchang District, ChongQing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency.","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"1615091","DOI":"10.3389\/fimmu.2025.1615091","article-title":"Anti-interferon-\u03b3 autoantibodies syndrome and opportunistic infections: systematic literature review.","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40257-022-00673-4","article-title":"New Practical Aspects of Sweet Syndrome.","volume":"23","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1346-8138.13167","article-title":"Clinical features and outcomes of Sweet\u2019s syndrome associated with non-tuberculous mycobacterial infection and other associated diseases.","volume":"43","author":"Chaowattanapanit","year":"2016","journal-title":"J Dermatol"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet syndrome: a review and update.","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1535370220981579","article-title":"Minireview: insights into anti-interferon-\u03b3 autoantibodies.","volume":"246","author":"Chawansuntati","year":"2021","journal-title":"Exp Biol Med (Maywood, N.J.)"},{"key":"R7-20260827","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of Anti-Interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States.","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","article-title":"Anti-IFN-\u03b3 autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection.","volume":"121","author":"Chi","year":"2013","journal-title":"Blood"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"e0128481","DOI":"10.1371\/journal.pone.0128481","article-title":"HLA-DRB1 and HLA-DQB1 are associated with adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies.","volume":"10","author":"Pithukpakorn","year":"2015","journal-title":"PLoS One"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"153134","DOI":"10.1016\/j.imbio.2025.153134","article-title":"The impact of neutralizing anti-IFN-\u03b3 autoantibodies on GBP5 expression and monocyte dysfunction in adult-onset immunodeficiency.","volume":"230","author":"Sornsuwan","year":"2025","journal-title":"Immunobiology"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections.","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid2206.151860","article-title":"Interferon-\u03b3 autoantibodies as predisposing factor for nontuberculous mycobacterial infection.","volume":"22","author":"Valour","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","article-title":"Rituximab restores IFN-\u03b3-STAT1 function and ameliorates disseminated mycobacterium avium infection in a patient with anti-interferon-\u03b3 autoantibody.","volume":"37","author":"Koizumi","year":"2017","journal-title":"J Clin Immunol"},{"key":"R14-20260827","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody.","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:30Z","timestamp":1787828490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049079","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2026-01-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}